Article Information
History
- August 26, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jerald Sadoff1,#,*,
- Mathieu Le Gars1,#,
- Vicky Cardenas2,
- Georgi Shukarev1,
- Nathalie Vaissiere3,
- Dirk Heerwegh3,
- Carla Truyers3,
- Anne Marit de Groot1,
- Gert Scheper1,
- Jenny Hendriks1,
- Javier Ruiz-Guiñazú3,
- Frank Struyf3,
- Johan Van Hoof1,
- Macaya Douoguih1 and
- Hanneke Schuitemaker1
- 1Janssen Vaccines and Prevention, Leiden, The Netherlands
- 2Janssen Research and Development, Spring House, PA, USA
- 3Janssen Research and Development, Beerse, Belgium
- ↵*Corresponding author; email: jsadoff{at}its.jnj.com
↵# contributed equally